Skip to main content

Advertisement

SpringerLink
Log in

Association of IL1Β (-511 A/C) and IL6 (-174 G > C) polymorphisms with higher disease activity and clinical pattern of psoriatic arthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The objective of this study is to analyze whether IL1β (-511G > A) and IL6 (-174 G > C) polymorphisms are associated with inflammatory activity, radiographic damage or clinical pattern of psoriatic arthritis (PsA). One hundred twenty-five patients classified as PsA according to the Classification of Psoriatic Arthritis (CASPAR) criteria were included. Patients were stratified according to their clinical pattern at inclusion as peripheral, axial, or mixed involvement. Disease activity in peripheral or mixed forms was measured using the number of swollen and tender joints, pain analog visual scale, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and disease activity score 28 (DAS28). Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) was used for axial and mixed forms, as were pain visual analog scale, ESR and CRP. Radiographic damage was evaluated using a modified Sharp score and modified stoke ankylosing spondylitis spinal score (SASSSm). The polymorphisms for the promoter region of IL1β (-511 G/A) and IL-6 (-174 G/C) were analyzed. The G allele of IL1B (-511G/A) polymorphism was associated with higher peripheral joint disease activity (OR 3.13; p < 0.0004; CI 95 % 1.43–6.82, p (corrected) <0.008), while the G allele of the IL6 (174G > C) polymorphism presented a strong trend to be associated with peripheral forms (70.86 %) (OR 1.89; p < 0.03; CI 95 % 1.06–3.39, p-corrected 0.05). In addition, this allele showed a lower association with HLA-B27 (15.78 %) compared with C allele (28.57 %) (OR 0.469; p = 0.02; CI 95 % 0.238–0.923, p-corrected 0.03). This study suggests that the G allele polymorphism of IL1B (-511 A/C) is associated with higher peripheral joint disease activity. On the other hand, the IL6 (-174 G/C) polymorphism showed a strong trend to be associated with the peripheral pattern of PsA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ghoreschi K, Laurence A, Yang X-P, Tato CM, McGeachy MJ, Konkel JE et al (2010) Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature 467(7318):967–71

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Lettesjö H, Nordström E, Ström H, Nilsson B, Glinghammar B, Dahlstedt L et al (1998) Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scand J Immunol 48(3):286–92

    Article  PubMed  Google Scholar 

  3. Ritchlin C, Haas-Smith SA, Hicks D, Cappuccio J, Osterland CK, Looney RJ (1998) Patterns of cytokine production in psoriatic synovium. J Rheumatol 25(8):1544–52

    CAS  PubMed  Google Scholar 

  4. Ravindran JS, Owen P, Lagan A, Lewis J, Korendowych E, Welsh K et al (2004) Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis. Rheumatology (Oxford) 43(1):22–6

    Article  CAS  Google Scholar 

  5. Peddle L, Butt C, Snelgrove T, Rahman P (2005) Interleukin (IL) 1alpha, IL1beta, IL receptor antagonist, and IL10 polymorphisms in psoriatic arthritis. Ann Rheum Dis 64(7):1093–4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Bowes J, Ho P, Flynn E, Salah S, McHugh N, FitzGerald O et al (2012) Investigation of IL1, VEGF, PPARG and MEFV genes in psoriatic arthritis susceptibility. Ann Rheum Dis 71(2):313–4

    Article  CAS  PubMed  Google Scholar 

  7. Eklund C, Jahan F, Pessi T, Lehtimäki T, Hurme M (2003) Interleukin 1B gene polymorphism is associated with baseline C-reactive protein levels in healthy individuals. Eur Cytokine Netw 14(3):168–71

    CAS  PubMed  Google Scholar 

  8. Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344(12):907–16

    Article  CAS  PubMed  Google Scholar 

  9. Alenius G-M, Eriksson C, Rantapää DS (2009) Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis? Clin Exp Rheumatol 27(1):120–3

    PubMed  Google Scholar 

  10. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S et al (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102(7):1369–76

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Wood NC, Symons JA, Dickens E, Duff GW (1992) In situ hybridization of IL-6 in rheumatoid arthritis. Clin Exp Immunol 87(2):183–9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Ceccarelli F, Perricone C, Fabris M, Alessandri C, Iagnocco A, Fabro C et al (2011) Transforming growth factor β 869C/T and interleukin 6–174G/C polymorphisms relate to the severity and progression of bone-erosive damage detected by ultrasound in rheumatoid arthritis. Arthritis Res Ther 13(4):R111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–73

    Article  PubMed  Google Scholar 

  14. Matthews JN, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300(6719):230–5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Van der Heijde D, Kavanaugh A, Gladman DD, Antoni C, Krueger GG, Guzzo C et al (2007) Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: results from the induction and maintenance psoriatic arthritis clinical trial 2. Arthritis Rheum 56(8):2698–707

    Article  PubMed  Google Scholar 

  16. Salaffi F, Carotti M, Garofalo G, Giuseppetti GM, Grassi W (2007) Radiological scoring methods for ankylosing spondylitis: a comparison between the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score. Clin Exp Rheumatol 25(1):67–74

    CAS  PubMed  Google Scholar 

  17. Fitzgerald O, Chandran V (2012) Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. J Rheumatol 39(2):427–30

    Article  CAS  PubMed  Google Scholar 

  18. Harrison P, Pointon JJ, Chapman K, Roddam A, Wordsworth BP (2008) Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis. Rheumatology 47(12):1768–70

    Article  CAS  PubMed  Google Scholar 

  19. Emonts M, Hazes MJMW, Houwing-Duistermaat JJ, van der Gaast-de Jongh CE, de Vogel L, Han HKH et al (2011) Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study. BMC Med Genet 12:36

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Jung N, Hellmann M, Hoheisel R, Lehmann C, Haase I, Perniok A et al (2010) An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX). Clin Rheumatol 29(10):1169–73

    Article  PubMed  Google Scholar 

  21. Cohen SB, Moreland LW, Cush JJ, Greenwald MW, Block S, Shergy WJ et al (2004) A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Ann Rheum Dis 63(9):1062–8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Pawlik A, Wrzesniewska J, Florczak M, Gawronska-Szklarz B, Herczynska M (2005) IL-6 promoter polymorphism in patients with rheumatoid arthritis. Scand J Rheumatol 34(2):109–13

    Article  CAS  PubMed  Google Scholar 

  23. François RJ, Neure L, Sieper J, Braun J (2006) Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Ann Rheum Dis 65(6):713–20

    Article  PubMed  Google Scholar 

  24. Paladini F, Taccari E, Fiorillo MT, Cauli A, Passiu G, Mathieu A et al (2005) Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondyloarthropathies. Arthritis Rheum 52(10):3319–21

    Article  CAS  PubMed  Google Scholar 

  25. Dalbeth N, Dockerty JL, Williamson L (2003) Influence of HLA-B27 on the clinical presentation of psoriatic arthritis. J Rheumatol 30(11):2511, author reply 2511–2

    PubMed  Google Scholar 

  26. Johnsen SS, Bakland G, Nossent JC (2014) The distribution of HLA-B27 subtype in patients with ankylosing spondylitis in Northern Norway. Scand J Rheumatol 43(4):296–300

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Ms Nieves Mateos for the technical help. This study was supported by a grant from the Fundación Española de Reumatología (to C. Montilla) and FIS PI PI13/01741.

Author information

Author notes

    Authors and Affiliations

    1. Rheumatology Service, University Hospital-IBSAL, Salamanca, Spain

      N. Cubino, C. Montilla, T. Carranco, I. Calero-Paniagua, A. Quesada, M. D. Sánchez, C. Hidalgo, O. Martínez & J. Del Pino-Montes

    2. Molecular Medicine Unit-IBSAL, University of Salamanca-University Hospital-CSIC, Salamanca, Spain

      R. Usategui-Martín, C. Cieza-Borrela & R. González-Sarmiento

    3. Institute for Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-CSIC, Salamanca, Spain

      R. González-Sarmiento

    4. Rheumatology of Hospital Clinic de Barcelona, Barcelona, Spain

      J. D. Cañete

    5. Rheumatology Hospital Universitario Central de Asturias, HUCA, Oviedo, Barcelona, Spain

      R. Queiro

    6. Anesthesiology Service, University Hospital-IBSAL, Salamanca, Spain

      A. Díaz-Álvarez

    7. Service of Rheumatology, Hospital Clínico Universitario de Salamanca, Paseo San Vicente 58-182, E-38007, Salamanca, Spain

      C. Montilla

    Authors
    1. N. Cubino
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. C. Montilla
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. R. Usategui-Martín
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. C. Cieza-Borrela
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. T. Carranco
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. I. Calero-Paniagua
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. A. Quesada
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. J. D. Cañete
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. R. Queiro
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. M. D. Sánchez
      View author publications

      You can also search for this author in PubMed Google Scholar

    11. C. Hidalgo
      View author publications

      You can also search for this author in PubMed Google Scholar

    12. O. Martínez
      View author publications

      You can also search for this author in PubMed Google Scholar

    13. J. Del Pino-Montes
      View author publications

      You can also search for this author in PubMed Google Scholar

    14. A. Díaz-Álvarez
      View author publications

      You can also search for this author in PubMed Google Scholar

    15. R. González-Sarmiento
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to C. Montilla.

    Ethics declarations

    Patients included in the study gave written informed consent. The Ethics committees of Hospital Universitario de Salamanca approved the study.

    Disclosures

    None.

    Additional information

    N. Cubino and C. Montilla contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Cubino, N., Montilla, C., Usategui-Martín, R. et al. Association of IL1Β (-511 A/C) and IL6 (-174 G > C) polymorphisms with higher disease activity and clinical pattern of psoriatic arthritis. Clin Rheumatol 35, 1789–1794 (2016). https://doi.org/10.1007/s10067-016-3301-2

    Download citation

    • Received:

    • Revised:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s10067-016-3301-2

    Keywords

    Search

    Navigation